Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.

Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, Kondo R, Yano H, Kage M, Nakano C, Aoki T, Aizawa N, Ikeda N, Takashima T, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Nishikawa H, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Ultrasound Med Biol. 2019 Jul 3. pii: S0301-5629(19)30243-1. doi: 10.1016/j.ultrasmedbio.2019.05.033. [Epub ahead of print]

PMID:
31277922
2.

A minimum of 100 tumor cells in a single biopsy sample is required to assess programmed cell death ligand 1 expression in predicting patient response to nivolumab treatment in non-squamous non-small cell lung carcinoma.

Naito T, Udagawa H, Sato J, Horinouchi H, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Ohe Y, Ishii G, Goto K.

J Thorac Oncol. 2019 Jun 28. pii: S1556-0864(19)30501-5. doi: 10.1016/j.jtho.2019.06.019. [Epub ahead of print]

PMID:
31260834
3.

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Jun 1;8(6). pii: E782. doi: 10.3390/jcm8060782.

4.

Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 May 8;8(5). pii: E634. doi: 10.3390/jcm8050634.

5.

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations.

Ikemura S, Yasuda H, Matsumoto S, Kamada M, Hamamoto J, Masuzawa K, Kobayashi K, Manabe T, Arai D, Nakachi I, Kawada I, Ishioka K, Nakamura M, Namkoong H, Naoki K, Ono F, Araki M, Kanada R, Ma B, Hayashi Y, Mimaki S, Yoh K, Kobayashi SS, Kohno T, Okuno Y, Goto K, Tsuchihara K, Soejima K.

Proc Natl Acad Sci U S A. 2019 May 14;116(20):10025-10030. doi: 10.1073/pnas.1819430116. Epub 2019 May 1.

6.

Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.

Naito T, Umemura S, Nakamura H, Zenke Y, Udagawa H, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Aokage K, Tsuboi M, Ishii G, Goto K.

Thorac Cancer. 2019 May;10(5):1285-1288. doi: 10.1111/1759-7714.13070. Epub 2019 Apr 10.

7.

Transcription Factor T-Bet Attenuates the Development of Elastase-Induced Emphysema in Mice.

Hayashi S, Matsuno Y, Tsunoda Y, Sakurai H, Kiwamoto T, Morishima Y, Ishii Y, Yoh K, Takahashi S, Hizawa N.

Am J Respir Cell Mol Biol. 2019 Apr 9. doi: 10.1165/rcmb.2018-0109OC. [Epub ahead of print]

PMID:
30965014
8.

Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.

Nakamura M, Kageyama SI, Niho S, Okumura M, Hojo H, Motegi A, Nakamura N, Zenda S, Yoh K, Goto K, Akimoto T.

Clin Lung Cancer. 2019 May;20(3):e256-e264. doi: 10.1016/j.cllc.2019.02.021. Epub 2019 Mar 4.

9.

Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.

Nishimura T, Iijima H, Nishikawa H, Kondo R, Yano H, Kage M, Aoki T, Nakano C, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Takashima T, Aizawa N, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Mar 18. doi: 10.1111/hepr.13332. [Epub ahead of print]

PMID:
30884015
10.

Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Mar 11;8(3). pii: E336. doi: 10.3390/jcm8030336.

11.

Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.

Esaki T, Hirai F, Makiyama A, Seto T, Bando H, Naito Y, Yoh K, Ishihara K, Kakizume T, Natsume K, Myers A, Doi T.

Cancer Sci. 2019 Apr;110(4):1340-1351. doi: 10.1111/cas.13956. Epub 2019 Feb 20.

12.

Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.

Chen X, Chang CW, Spoerke JM, Yoh KE, Kapoor V, Baudo C, Aimi J, Yu M, Liang-Chu MMY, Suttmann R, Huw LY, Gendreau S, Cummings C, Lackner MR.

Clin Cancer Res. 2019 Apr 1;25(7):2254-2263. doi: 10.1158/1078-0432.CCR-18-1593. Epub 2019 Jan 7.

PMID:
30617129
13.

Association of the Body Mass Index with the Presence of Gastroesophageal Varices in Compensated Cirrhotic Patients with Hepatitis C Viral Infection.

Enomoto H, Aizawa N, Ikeda N, Sakai Y, Takata R, Hasegawa K, Miyamoto Y, Inoue M, Nishimura T, Nakano C, Ishii N, Yuri Y, Yoh K, Ishii A, Takashima T, Nishikawa H, Iwata Y, Iijima H, Nishiguchi S.

Ann Clin Lab Sci. 2018 Nov;48(6):801-804.

PMID:
30610054
14.

Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 22;8(1). pii: E16. doi: 10.3390/jcm8010016.

15.

Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 15;7(12). pii: E553. doi: 10.3390/jcm7120553.

16.

Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.

Udagawa H, Umemura S, Murakami I, Mimaki S, Makinoshima H, Ishii G, Miyoshi T, Kirita K, Matsumoto S, Yoh K, Niho S, Tsuchihara K, Goto K.

Lung Cancer. 2018 Dec;126:182-188. doi: 10.1016/j.lungcan.2018.11.014. Epub 2018 Nov 12.

PMID:
30527185
17.

First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.

Doi T, Yoh K, Shitara K, Takahashi H, Ueno M, Kobayashi S, Morimoto M, Okusaka T, Ueno H, Morizane C, Okano N, Nagashima F, Furuse J.

Invest New Drugs. 2019 Jun;37(3):507-518. doi: 10.1007/s10637-018-0697-3. Epub 2018 Dec 4.

18.

Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.

Yoh K, Takamochi K, Shukuya T, Hishida T, Tsuboi M, Sakurai H, Goto Y, Yoshida K, Ohde Y, Okumura S, Ohashi Y, Kunitoh H.

Jpn J Clin Oncol. 2019 Jan 1;49(1):63-68. doi: 10.1093/jjco/hyy165.

PMID:
30452719
19.

Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B.

Hasegawa K, Nishikawa H, Enomoto H, Iwata Y, Sakai Y, Ikeda N, Takashima T, Aizawa N, Takata R, Yoh K, Ishii N, Yuri Y, Nishimura T, Iijima H, Hatano E, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Mar;49(3):271-283. doi: 10.1111/hepr.13280. Epub 2018 Nov 26.

PMID:
30358027
20.

The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis.

Nishikawa H, Yoh K, Enomoto H, Ishii N, Iwata Y, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Hasegawa K, Takashima T, Iijima H, Nishiguchi S.

Nutrients. 2018 Aug 29;10(9). pii: E1185. doi: 10.3390/nu10091185.

21.

Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis.

Nishikawa H, Yoh K, Enomoto H, Ishii N, Iwata Y, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Hasegawa K, Takashima T, Iijima H, Nishiguchi S.

Nutrients. 2018 Aug 12;10(8). pii: E1072. doi: 10.3390/nu10081072.

22.

Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer.

Nakamura M, Onozawa M, Motegi A, Hojo H, Zenda S, Nakamura N, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Akimoto T.

J Radiat Res. 2018 Nov 1;59(6):767-773. doi: 10.1093/jrr/rry066.

23.

Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction.

Enomoto H, Inoue SI, Matsuhisa A, Iwata Y, Aizawa N, Sakai Y, Takata R, Ikeda N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Miyamoto Y, Ishii N, Yuri Y, Ishii A, Takashima T, Nishikawa H, Iijima H, Nishiguchi S.

Mol Med Rep. 2018 Aug;18(2):2117-2123. doi: 10.3892/mmr.2018.9159. Epub 2018 Jun 14.

24.

Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.

Hosomi Y, Tanai C, Yoh K, Goto Y, Sakai H, Kato T, Kaburagi T, Nishio M, Kim YH, Inoue A, Hasegawa Y, Isobe H, Tomizawa Y, Mori Y, Minato K, Yamada K, Ohashi Y, Kunitoh H.

Expert Opin Pharmacother. 2018 Jul;19(10):1049-1056. doi: 10.1080/14656566.2018.1484903. Epub 2018 Jun 21.

PMID:
29871540
25.

Prognostic Impact of DNA Repair Protein Expression in Non-Small Cell Lung Cancers Treated with Platinum-Based Chemotherapy and Subsequent Curative Lung Resection.

Shin J, Lee KS, Yoh KA, Cho HJ, Choi MK, Kim SH, Kim YJ, Chung JH, Cho S, Kim K, Jheon S, Yoon HI, Lee JH, Lee CT, Lee JS.

Oncology. 2018;95(1):20-30. doi: 10.1159/000488201. Epub 2018 Apr 25.

PMID:
29694959
26.

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 16;5(1):e000196. doi: 10.1136/bmjgast-2017-000196. eCollection 2018.

27.

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 7;5(1):e000194. doi: 10.1136/bmjgast-2017-000194. eCollection 2018.

28.

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 14;5(1):e000193. doi: 10.1136/bmjgast-2017-000193. eCollection 2018.

29.

Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.

Kobayashi N, Iijima H, Tada T, Kumada T, Yoshida M, Aoki T, Nishimura T, Nakano C, Takata R, Yoh K, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Eur J Gastroenterol Hepatol. 2018 May;30(5):546-551. doi: 10.1097/MEG.0000000000001106.

PMID:
29494353
30.

A secondary RET mutation in the activation loop conferring resistance to vandetanib.

Nakaoku T, Kohno T, Araki M, Niho S, Chauhan R, Knowles PP, Tsuchihara K, Matsumoto S, Shimada Y, Mimaki S, Ishii G, Ichikawa H, Nagatoishi S, Tsumoto K, Okuno Y, Yoh K, McDonald NQ, Goto K.

Nat Commun. 2018 Feb 12;9(1):625. doi: 10.1038/s41467-018-02994-7.

31.

Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer.

Taira T, Yoh K, Nagase S, Kubota K, Ohmatsu H, Niho S, Onozawa M, Akimoto T, Ohe Y, Goto K.

Cancer Chemother Pharmacol. 2018 Mar;81(3):565-572. doi: 10.1007/s00280-018-3530-y. Epub 2018 Jan 31.

PMID:
29387962
32.

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.

Hisakane K, Yoh K, Nakamura N, Udagawa H, Kirita K, Umemura S, Matsumoto S, Niho S, Akimoto T, Tsuboi M, Goto K.

Medicine (Baltimore). 2017 Nov;96(47):e8635. doi: 10.1097/MD.0000000000008635.

33.

Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.

Kiura K, Yoh K, Katakami N, Nogami N, Kasahara K, Takahashi T, Okamoto I, Cantarini M, Hodge R, Uchida H.

Cancer Sci. 2018 Apr;109(4):1177-1184. doi: 10.1111/cas.13511. Epub 2018 Feb 27.

34.

Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Jan 4;5(1):e000190. doi: 10.1136/bmjgast-2017-000190. eCollection 2018.

35.

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.

Takata R, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2017 Dec;96(48):e8761. doi: 10.1097/MD.0000000000008761.

36.

Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Dec 10;4(1):e000185. doi: 10.1136/bmjgast-2017-000185. eCollection 2017.

37.

Efficacy of capsule endoscopy in patients with cirrhosis for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities: a study protocol for prospective interventional study.

Iwata Y, Nishikawa H, Enomoto H, Yoh K, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Sep 14;4(1):e000168. doi: 10.1136/bmjgast-2017-000168. eCollection 2017.

38.

Differentiation of IL-17-Producing Invariant Natural Killer T Cells Requires Expression of the Transcription Factor c-Maf.

Yu JS, Hamada M, Ohtsuka S, Yoh K, Takahashi S, Miaw SC.

Front Immunol. 2017 Oct 27;8:1399. doi: 10.3389/fimmu.2017.01399. eCollection 2017.

39.

Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.

Hisakane K, Ohmatsu H, Umemura S, Kirita K, Matsumoto S, Yoh K, Niho S, Goto K.

J Nippon Med Sch. 2017;84(5):231-236. doi: 10.1272/jnms.84.231.

40.

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.

Seto T, Hirai F, Saka H, Kogure Y, Yoh K, Niho S, Fukase K, Shimada H, Sasai M, Fukino K.

Jpn J Clin Oncol. 2018 Jan 1;48(1):31-42. doi: 10.1093/jjco/hyx144.

PMID:
29136201
41.

Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.

Ishii N, Iwata Y, Nishikawa H, Enomoto H, Aizawa N, Ishii A, Miyamoto Y, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

Oncol Lett. 2017 Nov;14(5):6059-6065. doi: 10.3892/ol.2017.6952. Epub 2017 Sep 15.

42.

Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: a study protocol for single-arm, prospective, interventional study.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Sep 29;4(1):e000177. doi: 10.1136/bmjgast-2017-000177. eCollection 2017.

43.

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.

Yoh K, Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

Nutrients. 2017 Oct 18;9(10). pii: E1135. doi: 10.3390/nu9101135.

44.

Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study.

Goto Y, Tanai C, Yoh K, Hosomi Y, Sakai H, Kato T, Kaburagi T, Nishio M, Kim YH, Inoue A, Hasegawa Y, Isobe H, Tomizawa Y, Mori Y, Minato K, Yamada K, Ohashi Y, Kunitoh H.

ESMO Open. 2017 Sep 14;2(4):e000214. doi: 10.1136/esmoopen-2017-000214. eCollection 2017.

45.

Transcription factor MafB may play an important role in secondary hyperparathyroidism.

Morito N, Yoh K, Usui T, Oishi H, Ojima M, Fujita A, Koshida R, Shawki HH, Hamada M, Muratani M, Yamagata K, Takahashi S.

Kidney Int. 2018 Jan;93(1):54-68. doi: 10.1016/j.kint.2017.06.023. Epub 2017 Sep 28.

PMID:
28964572
46.

Erratum to: Attempt at standardization of bone quantitative ultrasound in Japan.

Otani T, Fukunaga M, Yoh K, Miki T, Yamazaki K, Kishimoto H, Matsukawa M, Endoh N, Hachiya H, Kanai H, Fujiwara S, Nagai Y.

J Med Ultrason (2001). 2018 Jan;45(1):15. doi: 10.1007/s10396-017-0832-3.

PMID:
28933006
47.

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Kubota K, Yoshioka H, Oshita F, Hida T, Yoh K, Hayashi H, Kato T, Kaneda H, Yamada K, Tanaka H, Ichinose Y, Park K, Cho EK, Lee KH, Lin CB, Yang JC, Hara K, Asato T, Nakagawa K.

J Clin Oncol. 2017 Nov 10;35(32):3662-3670. doi: 10.1200/JCO.2017.72.7297. Epub 2017 Sep 13.

PMID:
28902534
48.

Attempt at standardization of bone quantitative ultrasound in Japan.

Otani T, Fukunaga M, Yoh K, Miki T, Yamazaki K, Kishimoto H, Matsukawa M, Endoh N, Hachiya H, Kanai H, Fujiwara S, Nagai Y.

J Med Ultrason (2001). 2018 Jan;45(1):3-13. doi: 10.1007/s10396-017-0814-5. Epub 2017 Sep 7. Review. Erratum in: J Med Ultrason (2001). 2017 Sep 20;:.

PMID:
28884290
49.

T-bet, but not Gata3, overexpression is detrimental in a neurotropic viral infection.

Sato F, Kawai E, Martinez NE, Omura S, Park AM, Takahashi S, Yoh K, Tsunoda I.

Sci Rep. 2017 Sep 5;7(1):10496. doi: 10.1038/s41598-017-10980-0.

50.

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.

Yuri Y, Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

J Cancer. 2017 Jun 1;8(9):1507-1516. doi: 10.7150/jca.19175. eCollection 2017.

Supplemental Content

Support Center